Why is Czechia a key player in our CEE network❓
📋 EU High Enroller – joined the EU in 2004
⏱️ Regulatory pathway aligned with EU/EMA standards ➡️ total approval in 60 days
⚕️ Universal healthcare system simplifies trial management and communication
🏥 Strong research infrastructure, with public hospitals and an expanding private sector
🩺 Highly educated, multilingual, and motivated healthcare professionals
🤝 Czech patients show a high level of willingness to participate in clinical research which is a critical success factor
The country provides access to treatment-naive patient populations across key therapeutic areas.
🩷 Cardiology
🎗️ Oncology
🧠 Neurology
🫁 Pulmonology
➡️ and more!